Treatment of Symptomatic Focal Hepatic Hemangioma with Propranolol in Neonates: Is It Efficient?
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hepatic hemangiomas (HH) – classified into congenital hepatic hemangiomas (CHH) or infantile hepatic hemangiomas (IHH) – are benign vascular tumors that are mainly asymptomatic, but may cause clinical problems that require treatment. While focal, multifocal, and diffuse IHH are responsive to propranolol treatment, CHH is mainly focal and thought to be resistant to treatment with propranolol. The clinical and imaging distinctions between CHH and IHH in cases of focal lesions can be challenging, while histopathological distinction is mostly lacking in the clinical setting. We report 4 neonatal symptomatic cases of focal HH treated with propranolol, with partial or complete resolution of the tumor, and the positive hemodynamic effect of propranolol in one case. We believe that although clear differentiation cannot be achieved between CHH and IHH without histopathological examination in cases of focal HH in neonates, propranolol treatment should be attempted in symptomatic cases since its benefits outweigh the possible small risk of side effects of propranolol.
Abstract
Hepatic hemangiomas (HH) – classified into congenital hepatic hemangiomas (CHH) or infantile hepatic hemangiomas (IHH) – are benign vascular tumors that are mainly asymptomatic, but may cause clinical problems that require treatment. While focal, multifocal, and diffuse IHH are responsive to propranolol treatment, CHH is mainly focal and thought to be resistant to treatment with propranolol. The clinical and imaging distinctions between CHH and IHH in cases of focal lesions can be challenging, while histopathological distinction is mostly lacking in the clinical setting. We report 4 neonatal symptomatic cases of focal HH treated with propranolol, with partial or complete resolution of the tumor, and the positive hemodynamic effect of propranolol in one case. We believe that although clear differentiation cannot be achieved between CHH and IHH without histopathological examination in cases of focal HH in neonates, propranolol treatment should be attempted in symptomatic cases since its benefits outweigh the possible small risk of side effects of propranolol.
참고문헌 (18)
- Iacobas I, "Guidance document for hepatic hemangioma(infantile and congenital)evaluation and monitoring", J Pediatr, 203, pp.294~300 (2018)[DOI]
- Wassef M, "Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies", Pediatrics, 136, pp.e203~e214 (2015)
- Gnarra M, "History of the infantile hepatic hemangioma : from imaging to generating a differential diagnosis", World J Clin Pediatr, 5, pp.273~280 (2016)
- Zavras N, "Infantile hepatic hemangioma : current state of the art, controversies, and perspectives", Eur J Pediatr, 179, pp.1~8 (2020)
- Kulungowski AM, "Lessons from a liver hemangioma registry : subtype classification", J Pediatr Surg, 47, pp.165~170 (2012)
- Christison-Lagay ER, "Hepatic hemangiomas : subtype classification and development of a clinical practice algorithm and registry", J Pediatr Surg, 42, pp.62~67 (2007)
- Liang MG, "Infantile and congenital hemangiomas", Semin Pediatr Surg, 23, pp.162~167 (2014)
- Mhanna A, "Hepatic infantile hemangiomas treated with oral propranolol--a case series", Pediatr Dermatol, 28, pp.39~45 (2011)
- Sarıalioğlu F, "A new perspective for infantile hepatic hemangioma in the age of propranolol : experience at Baskent University", Exp Clin Transplant, 15(Suppl 2), pp.74~78 (2017)
- Lukas Ernst, "Infantile Hepatic Hemangioma: Avoiding Unnecessary Invasive Procedures", Pediatric Gastroenterology, Hepatology & Nutrition, 23(1), pp.72~78 (2020), 대한소아소화기영양학회[DOI]
- Florian-Tutaya LS, "Successful use of propranolol in a symptomatic giant congenital hepatic hemangioma", J Neonatol, 34, pp.99~102 (2020)
- Kawahara Y, "Successful use of propranolol for congenital hepatic hemangioma with Kasabach-Merritt phenomenon", Pediatr Int, 59, pp.634~636 (2017)
- Docx MKF, "Propranolol therapy for an abdominal giant haemangioma in a neonate", J Nepal Paediatr Soc, 35, pp.189~191 (2015)
- Baena-Gómez MA, "Hepatic hemangiomas: spectacular response to treatment with propranolol", An Pediatr(Barc), 83, pp.435~437 (2015)[DOI]
- Tsai MC, "Efficacy of infantile hepatic hemangioma with propranolol treatment : a case report", Medicine(Baltimore), 98, pp.e14078~ (2019)
- Lekwuttikarn R, "Successful medical management of life-threatening hepatic hemangioma in neonates", Pediatrics, 144, pp.e20191339~ (2019)
- Lewis D, "Rapidly involuting congenital haemangioma of the liver", BMJ Case Rep, 2018 (2018)
- Koh SP, "β-blocker therapy for infantile hemangioma", Expert Rev Clin Pharmacol, 13, pp.899~915 (2020)